About Careers Internship MedBlog Contact us
Medindia LOGIN REGISTER
Advertisement

Now, Single Jab That Could Prevent Blindness

by VR Sreeraman on October 15, 2009 at 2:36 PM
 Now, Single Jab That Could Prevent Blindness

A single jab can now prevent people from losing their vision, thanks to researchers at Trinity College Dublin, Ireland, who have developed a new method to inject drug into the blood by weakening the otherwise impermeable blood-retina barrier.

The blood-retina barrier normally prevents molecules in the blood from reaching the retina.

Advertisement

Presently, drugs to treat age-related macular degeneration, the leading cause of blindness in the west, have to be injected into the eyeball once a month, which can cause eye infections and even blindness in 1 out of 50 injections.

But now, researchers led by Matthew Campbell have now restored the vision of mice by temporarily weakening the blood-retina barrier to let drug molecules injected into the blood slip through.
Advertisement

Using a technique called RNA interference (RNAi), they could block the production of claudin-5-a protein that normally helps make the blood-retina barrier impermeable.

"It's proof of principle," New Scientist quoted Campbell as saying.

However, RNAi therapy is not yet safe enough for use in people, as it would breach the blood-brain barrier as well as the blood-retina barrier.

The team are already working on a way to block claudin-5 production in the eye only.

This method involves gene therapy using a modified virus that makes the RNA only in the presence of an antibiotic called doxycycline.

With the novel approach, patients would need only one initial injection into their eye to deliver the virus.

Then once a month they would take the antibiotic orally, and two days later the drug to treat blindness would be injected in their blood.

By then the blood-retina barrier would be sufficiently weakened to allow the drug to pass through.

Although the existing drugs to treat age-related macular degeneration would be too big to pass through the barrier, there are other molecules in development that are small enough.

Some of these could be taken orally when the barrier goes down.

The study has been published in Proceedings of the National Academy of Sciences.

Source: ANI
LIN
Font : A-A+

Advertisement

Advertisement
Advertisement

Latest Research News

Insight into Cellular Stress: Mechanisms Behind mRNA Sequestration Revealed
The discovery deepens our understanding of m6A biology and stress granule formation, with implications for neurodegenerative diseases.
Disrupted Circadian Rhythm Elevates the Risk of Parkinson's Disease
Trouble with sleep and the body's clock may increase your risk for Parkinson's, as per a new study.
A Wake-Up Call for Women  Hot Flashes Could Point to Alzheimer's Risk
New study uncovers a link between nocturnal hot flashes and Alzheimer's risk in menopausal women, suggesting a potential biomarker.
Breakthrough Brain-Centered Approach Reduces Chronic Back Pain
Our discovery revealed that a minority of individuals attributed their chronic pain to their brain's involvement.
New Statement to Protect Athletes' Health Published
Relative Energy Deficiency in Sport syndrome is overlooked by athletes and can be worsened by 'sports culture' due to its perceived short-term performance benefits.
View All
This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close
MediBotMediBot
Greetings! How can I assist you?MediBot
×

Now, Single Jab That Could Prevent Blindness Personalised Printable Document (PDF)

Please complete this form and we'll send you a personalised information that is requested

You may use this for your own reference or forward it to your friends.

Please use the information prudently. If you are not a medical doctor please remember to consult your healthcare provider as this information is not a substitute for professional advice.

Name *

Email Address *

Country *

Areas of Interests